- -

Analysis of the prognostic value of soluble epidermal growth factor receptor plasma concentration in advanced non-small-cell lung cancer patients

RiuNet: Repositorio Institucional de la Universidad Politécnica de Valencia

Compartir/Enviar a

Citas

Estadísticas

Analysis of the prognostic value of soluble epidermal growth factor receptor plasma concentration in advanced non-small-cell lung cancer patients

Mostrar el registro completo del ítem

Jantus Lewintre, E.; Sirera Pérez, R.; Cabrera, A.; Blasco, A.; Caballero, C.; Iranzo, V.; Rosell, R.... (2011). Analysis of the prognostic value of soluble epidermal growth factor receptor plasma concentration in advanced non-small-cell lung cancer patients. Clinical Lung Cancer. 12(5):320-327. doi:10.1016/j.cllc.2011.03.031.

Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10251/65056

Ficheros en el ítem

Metadatos del ítem

Título: Analysis of the prognostic value of soluble epidermal growth factor receptor plasma concentration in advanced non-small-cell lung cancer patients
Autor:
Entidad UPV: Universitat Politècnica de València. Departamento de Biotecnología - Departament de Biotecnologia
Fecha difusión:
Resumen:
[EN] Background: Epidermal growth factor receptor (EGFR) is overexpressed in a variety of epithelial malignancies including lung cancer. A soluble fragment of the EGFR extracellular domain (sEGFR) can be detected in the ...[+]
Palabras clave: Biomarker , EGFR prognostic , NSCLC , Cisplatin , Docetaxel , Epidermal growth factor receptor , Erlotinib , Gefitinib , Adult , Advanced cancer , Aged , Article , Cancer combination chemotherapy , Cancer growth , Cancer localization , Cancer patient , Cancer survival , Cohort analysis , Controlled study , Disease course , Disease severity , Distant metastasis , Enzyme linked immunosorbent assay , Female , Functional status , Gender , Human , Human tissue , Large cell carcinoma , Lung adenocarcinoma , Lung metastasis , Lung non small cell cancer , Lung squamous cell carcinoma , Major clinical study , Male , Multiple cycle treatment , Overall survival , Prognosis , Protein blood level , Receiver operating characteristic , Retrospective study , Sensitivity and specificity , Survival time , Adenocarcinoma , Aged, 80 and over , Carcinoma, Non-Small-Cell Lung , Carcinoma, Squamous Cell , Case-Control Studies , Disease Progression , Enzyme-Linked Immunosorbent Assay , Humans , Lung Neoplasms , Middle Aged , Multivariate Analysis , Receptor, Epidermal Growth Factor , Retrospective Studies , Survival Rate , Tumor Markers, Biological
Derechos de uso: Cerrado
Fuente:
Clinical Lung Cancer. (issn: 1525-7304 )
DOI: 10.1016/j.cllc.2011.03.031
Editorial:
Elsevier
Versión del editor: https://dx.doi.org/10.1016/j.cllc.2011.03.031
Patrocinador:
Spanish Society of Medical Oncology (SEOM)
Red Tematica de Investigacion Cooperativa en Cancer (RTICC) RD06/0020/1024
Instituto de Salud Carlos III (ISCIII)
Spanish Ministry of Science and Innovation
European Regional Development Fund (ERDF) "Una manera de hacer Europa"
Tipo: Artículo

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro completo del ítem